The fixed-price contract allows for an additional $170 million in potential purchases at the discretion of the Energy Department, pushing the total valuation to over $1 billion. This expansion follows the successful completion of a previous demonstration phase in mid-June, which yielded 1,900 kilograms of uranium hexafluoride. To facilitate this transition, Centrus is negotiating a long-term lease extension for the American Centrifuge Plant, aiming to bring the first phase of commercial capacity online by 2029.

Once fully operational, the site will provide 12 metric tons of annual high-assay, low-enriched uranium capacity. This infrastructure is intended to satisfy the company’s existing $2.4 billion backlog for standard low-enriched uranium while simultaneously ramping up the specialized fuel production required for advanced reactor designs.